A case of multifocal papillary thyroid carcinoma consisting of one encapsulated follicular variant with BRAF K601E mutation and three conventional types with BRAF V600E mutation

Korean Journal of Pathology

Volumn 47, Issue 3, 2013, Pages 293-298

  Kim, Wook Youn ^a   Ko, Young SinYoung Sin ^a   Hwang, Tae Sook ^a   Han, Hye Seung ^a   Lim, So Dug ^a   Kim, Wan Seop ^a   Oh, Seo Young ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

BRAF K601E; BRAF V600E; Carcinoma; Papillary; Thyroid gland

Indexed keywords

EID: 84882714061     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2013.47.3.293     Document Type: Article

References (20)

1. Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 2006; 107: 1255-64.
2. Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer 2005; 12: 245-62.
3. Kim SK, Hwang TS, Yoo YB, et al. Surgical results of thyroid nodules according to a management guideline based on the BRAF (V600E) mutation status. J Clin Endocrinol Metab 2011; 96: 658-64.
4. Trovisco V, Vieira de Castro I, Soares P, et al. BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 2004; 202: 247-51.
5. Jovanovic L, Delahunt B, McIver B, et al. Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma. Pathology 2010; 42: 524-33.
6. Wreesmann VB, Ghossein RA, Hezel M, et al. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer 2004; 40: 355-64.
7. Sobrinho-Simões M, Preto A, Rocha AS, et al. Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch 2005; 447: 787-93.
8. Katoh R, Sasaki J, Kurihara H, Suzuki K, Iida Y, Kawaoi A. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma: a clinicopathologic study of 105 consecutive patients. Cancer 1992; 70: 1585-90.
9. Giannini R, Ugolini C, Lupi C, et al. The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma. J Clin Endocrinol Metab 2007; 92: 3511-6.
10. Shattuck TM, Westra WH, Ladenson PW, Arnold A. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med 2005; 352: 2406-12.
11. Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Grebe SK. Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone. J Pathol 2008; 215: 145-54.
12. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985; 55: 805-28.
13. Pennelli G, Vianello F, Barollo S, et al. BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. Thyroid 2011; 21: 1393-6.
14. Jeong JY, Jang JS, Sohn YK, Jung JH, Chun YK, Park JY. Availability of immunohistochemistry in the diagnosis of follicular variant of papillary thyroid carcinoma. Korean J Pathol 2010; 44: 48-55.
15. Min HS, Choe G, Cho NY, Kang GH, Park SH, Park SY. Immunohistochemical and molecular characteristics of follicular patterned thyroid nodules with incomplete nuclear features of papillary thyroid carcinoma. Korean J Pathol 2009; 43: 495-502.
16. Zhu X, Sun T, Lu H, et al. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma. J Clin Pathol 2010; 63: 786-9.
17. Park YJ, Kwak SH, Kim DC, et al. Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules. J Korean Med Sci 2007; 22: 621-8.
18. Schindler AM, van Melle G, Evequoz B, Scazziga B. Prognostic factors in papillary carcinoma of the thyroid. Cancer 1991; 68: 324-30.
19. Chan J. Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 2002; 117: 16-8.
20. Wan PT, Garnett MJ, Roe SM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 2004; 116: 855-67.